Us Manufacturing Ism

Feb 04, 2016 at 11:56 | Source: CNBC-TV18
A report today said the US government has made it mandatory for all active pharmaceutical ingredients (APIs) to be manufactured locally. But analysts said it was unlikely such a law could have been passed.
Feb 04, 2016 at 08:36 | Source: CNBC-TV18
Speaking to CNBC-TV18, James Glassman, Senior Economist at JP Morgan says the Federal Reserve will be in no hurry to raise rates post the weak data.
Feb 03, 2016 at 14:28 | Source: PTI
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Isosulfan Blue injection 1 percent (50 mg/5 mL) single-dose vials, Aurobindo Pharma said in a statement.
Feb 03, 2016 at 11:28 | Source: Moneycontrol.com
This is third approval received by the company in the last two days. Yesterday, the company had received two approvals from USFDA to manufacture and market Celecoxib Capsules and Levetiracetam Injection USP.
Feb 03, 2016 at 10:47 | Source: Moneycontrol.com
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Isosulfan Blue Injection, 1% (50 mg/5 mL) single-dose vials.
Feb 02, 2016 at 19:00 | Source: PTI
"The Make-in-India initiative offers US high-tech companies the chance to sell equipment to Indian manufacturers harnessing the globally competitive resources of innovators right here in India," Export Import Bank (EXIM) of the United States Chairman Fred P Hochberg said here.
Feb 02, 2016 at 12:07 | Source: Moneycontrol.com
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg. This product is expected to be launched in Q4 FY15-16.
Feb 02, 2016 at 11:56 | Source: Moneycontrol.com
According to Angel Broking, Euro is expected to trade positive owing to weakness seen in the US Dollar Index after the disappointing release of manufacturing data from the nation that will act as a positive factor for the currency.
Feb 01, 2016 at 06:00 | Source: Mecklai Financial
US manufacturing remains worrisome
Jan 27, 2016 at 15:12 | Source: PTI
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Voriconazole tablets in the strengths of 50 mg and 200 mg, Aurobindo Pharma said in a statement.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.